188 related articles for article (PubMed ID: 21440438)
1. Impaired neuromuscular transmission and response to acetylcholinesterase inhibitors in centronuclear myopathies.
Robb SA; Sewry CA; Dowling JJ; Feng L; Cullup T; Lillis S; Abbs S; Lees MM; Laporte J; Manzur AY; Knight RK; Mills KR; Pike MG; Kress W; Beeson D; Jungbluth H; Pitt MC; Muntoni F
Neuromuscul Disord; 2011 Jun; 21(6):379-86. PubMed ID: 21440438
[TBL] [Abstract][Full Text] [Related]
2. Neuromuscular junction abnormalities in DNM2-related centronuclear myopathy.
Gibbs EM; Clarke NF; Rose K; Oates EC; Webster R; Feldman EL; Dowling JJ
J Mol Med (Berl); 2013 Jun; 91(6):727-37. PubMed ID: 23338057
[TBL] [Abstract][Full Text] [Related]
3. Congenital myopathies with secondary neuromuscular transmission defects; a case report and review of the literature.
Rodríguez Cruz PM; Sewry C; Beeson D; Jayawant S; Squier W; McWilliam R; Palace J
Neuromuscul Disord; 2014 Dec; 24(12):1103-10. PubMed ID: 25127990
[TBL] [Abstract][Full Text] [Related]
4. β2-Adrenergic receptor agonists ameliorate the adverse effect of long-term pyridostigmine on neuromuscular junction structure.
Vanhaesebrouck AE; Webster R; Maxwell S; Rodriguez Cruz PM; Cossins J; Wickens J; Liu WW; Cetin H; Cheung J; Ramjattan H; Palace J; Beeson D
Brain; 2019 Dec; 142(12):3713-3727. PubMed ID: 31633155
[TBL] [Abstract][Full Text] [Related]
5. Neuromuscular transmission defects in myopathies: Rare but worth searching for.
Elahi B; Laughlin RS; Litchy WJ; Milone M; Liewluck T
Muscle Nerve; 2019 Apr; 59(4):475-478. PubMed ID: 30536954
[TBL] [Abstract][Full Text] [Related]
6. Neuromuscular blocking effects of cisatracurium and its antagonism with neostigmine in a canine model of autosomal-recessive centronuclear myopathy.
Martin-Flores M; Paré MD; Campoy L; Gleed RD
Br J Anaesth; 2015 Dec; 115(6):927-31. PubMed ID: 26582854
[TBL] [Abstract][Full Text] [Related]
7. X-linked myotubular and centronuclear myopathies.
Pierson CR; Tomczak K; Agrawal P; Moghadaszadeh B; Beggs AH
J Neuropathol Exp Neurol; 2005 Jul; 64(7):555-64. PubMed ID: 16042307
[TBL] [Abstract][Full Text] [Related]
8. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
[TBL] [Abstract][Full Text] [Related]
9. X-linked myotubular myopathy is associated with epigenetic alterations and is ameliorated by HDAC inhibition.
Volpatti JR; Ghahramani-Seno MM; Mansat M; Sabha N; Sarikaya E; Goodman SJ; Chater-Diehl E; Celik A; Pannia E; Froment C; Combes-Soia L; Maani N; Yuki KE; Chicanne G; Uusküla-Reimand L; Monis S; Alvi SA; Genetti CA; Payrastre B; Beggs AH; Bonnemann CG; Muntoni F; Wilson MD; Weksberg R; Viaud J; Dowling JJ
Acta Neuropathol; 2022 Sep; 144(3):537-563. PubMed ID: 35844027
[TBL] [Abstract][Full Text] [Related]
10. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
[TBL] [Abstract][Full Text] [Related]
11. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
[TBL] [Abstract][Full Text] [Related]
12. Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models.
Dowling JJ; Joubert R; Low SE; Durban AN; Messaddeq N; Li X; Dulin-Smith AN; Snyder AD; Marshall ML; Marshall JT; Beggs AH; Buj-Bello A; Pierson CR
Dis Model Mech; 2012 Nov; 5(6):852-9. PubMed ID: 22645112
[TBL] [Abstract][Full Text] [Related]
13. Centronuclear (myotubular) myopathy.
Jungbluth H; Wallgren-Pettersson C; Laporte J
Orphanet J Rare Dis; 2008 Sep; 3():26. PubMed ID: 18817572
[TBL] [Abstract][Full Text] [Related]
14. Non-compaction cardiomyopathy and early respiratory failure in an adult symptomatic female carrier of centronuclear myopathy caused by a MTM1 mutation.
García-García J; Fernández-García MA; Blanco-Arias P; Díaz-Maroto-Cicuendez MI; Salmerón-Martínez F; Hidalgo-Olivares VM; Olivé M
Neuromuscul Disord; 2018 Nov; 28(11):952-955. PubMed ID: 30241883
[TBL] [Abstract][Full Text] [Related]
15. Loss of catalytically inactive lipid phosphatase myotubularin-related protein 12 impairs myotubularin stability and promotes centronuclear myopathy in zebrafish.
Gupta VA; Hnia K; Smith LL; Gundry SR; McIntire JE; Shimazu J; Bass JR; Talbot EA; Amoasii L; Goldman NE; Laporte J; Beggs AH
PLoS Genet; 2013 Jun; 9(6):e1003583. PubMed ID: 23818870
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.
Danièle N; Moal C; Julien L; Marinello M; Jamet T; Martin S; Vignaud A; Lawlor MW; Buj-Bello A
J Neuropathol Exp Neurol; 2018 Apr; 77(4):282-295. PubMed ID: 29408998
[TBL] [Abstract][Full Text] [Related]
17. Systemic AAV8-Mediated Gene Therapy Drives Whole-Body Correction of Myotubular Myopathy in Dogs.
Mack DL; Poulard K; Goddard MA; Latournerie V; Snyder JM; Grange RW; Elverman MR; Denard J; Veron P; Buscara L; Le Bec C; Hogrel JY; Brezovec AG; Meng H; Yang L; Liu F; O'Callaghan M; Gopal N; Kelly VE; Smith BK; Strande JL; Mavilio F; Beggs AH; Mingozzi F; Lawlor MW; Buj-Bello A; Childers MK
Mol Ther; 2017 Apr; 25(4):839-854. PubMed ID: 28237839
[TBL] [Abstract][Full Text] [Related]
18. A Study of a Cohort of X-Linked Myotubular Myopathy at the Clinical, Histologic, and Genetic Levels.
Abath Neto O; Silva MR; Martins Cde A; Oliveira Ade S; Reed UC; Biancalana V; Pesquero JB; Laporte J; Zanoteli E
Pediatr Neurol; 2016 May; 58():107-12. PubMed ID: 26995067
[TBL] [Abstract][Full Text] [Related]
19. Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.
Gómez-Oca R; Cowling BS; Laporte J
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768808
[TBL] [Abstract][Full Text] [Related]
20. Affected female carriers of MTM1 mutations display a wide spectrum of clinical and pathological involvement: delineating diagnostic clues.
Biancalana V; Scheidecker S; Miguet M; Laquerrière A; Romero NB; Stojkovic T; Abath Neto O; Mercier S; Voermans N; Tanner L; Rogers C; Ollagnon-Roman E; Roper H; Boutte C; Ben-Shachar S; Lornage X; Vasli N; Schaefer E; Laforet P; Pouget J; Moerman A; Pasquier L; Marcorelle P; Magot A; Küsters B; Streichenberger N; Tranchant C; Dondaine N; Schneider R; Gasnier C; Calmels N; Kremer V; Nguyen K; Perrier J; Kamsteeg EJ; Carlier P; Carlier RY; Thompson J; Boland A; Deleuze JF; Fardeau M; Zanoteli E; Eymard B; Laporte J
Acta Neuropathol; 2017 Dec; 134(6):889-904. PubMed ID: 28685322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
